AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.04% | 9.10% | 6.65% | 8.39% | 5.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.04% | 9.10% | 6.65% | 8.39% | 5.60% |
| Cost of Revenue | 7.94% | 5.94% | 3.43% | -1.50% | 0.86% |
| Gross Profit | 10.85% | 10.40% | 7.96% | 13.27% | 7.56% |
| SG&A Expenses | 3.61% | -15.19% | -3.95% | 5.14% | 3.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00% | -- | -- | -- | -104.14% |
| Total Operating Expenses | 7.42% | -1.40% | 1.82% | 3.92% | 3.73% |
| Operating Income | 15.48% | 35.30% | 15.79% | 20.23% | 9.70% |
| Income Before Tax | 217.58% | -65.74% | -27.59% | -5.36% | -287.21% |
| Income Tax Expenses | 137.98% | 1.15% | -20.70% | -2.87% | -678.87% |
| Earnings from Continuing Operations | 7,991.30% | -87.98% | -31.46% | -6.05% | -102.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 33.33% | 0.00% | 0.00% | 150.00% |
| Net Income | 8,354.55% | -88.08% | -31.53% | -6.06% | -102.68% |
| EBIT | 15.48% | 35.30% | 15.79% | 20.23% | 9.70% |
| EBITDA | 9.20% | 23.24% | 9.93% | 11.89% | 7.02% |
| EPS Basic | 5,724.31% | -88.65% | -31.76% | -6.05% | -103.95% |
| Normalized Basic EPS | 17.63% | 37.25% | 12.98% | 17.14% | 5.64% |
| EPS Diluted | 5,543.85% | -88.65% | -32.40% | -6.27% | -104.09% |
| Normalized Diluted EPS | 17.63% | 37.25% | 12.97% | 17.13% | 5.64% |
| Average Basic Shares Outstanding | 0.28% | 0.00% | 0.00% | -0.06% | -0.17% |
| Average Diluted Shares Outstanding | 0.28% | 0.00% | 0.00% | -0.06% | -0.17% |
| Dividend Per Share | 5.49% | 5.81% | 5.81% | 5.81% | 5.81% |
| Payout Ratio | 1.01% | 7.88% | 0.55% | 0.12% | -40.16% |